Dehydroepiandrosterone Sulfate Levels and Pulse Wave Velocity in Elderly Men

[Aim] To determine the relationship between dehydroepiandrosterone sulfate (DHEAS) levels and brachial-ankle pulse wave velocity (baPWV) in men. [Methods] The subjects were 114 men aged 59.1 ± 16.6 years, after exclusion of patients undergoing treatment for hypertension, diabetes and hyperlipidemia...

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Cardiovascular Disease Prevention Vol. 40; no. 2; pp. 116 - 122
Main Authors Takagi, Satoru, Isobe, Takeshi, Katoh, Nobuo, Fujiwara, Tadashi, Takeuchi, Hiroshi, Shimamoto, Kazuaki, Nakamura, Yosuke, Chiba, Yu, Saitoh, Shigeyuki
Format Journal Article
LanguageJapanese
Published The Japanese Association for Cerebro-cardiovascular Disease Control 2005
社団法人 日本循環器管理研究協議会
Subjects
Online AccessGet full text
ISSN1346-6267
DOI10.11381/jjcdp2001.40.116

Cover

Abstract [Aim] To determine the relationship between dehydroepiandrosterone sulfate (DHEAS) levels and brachial-ankle pulse wave velocity (baPWV) in men. [Methods] The subjects were 114 men aged 59.1 ± 16.6 years, after exclusion of patients undergoing treatment for hypertension, diabetes and hyperlipidemia and patients with ABI of 0.9 or less, who participated in mass-screening tests in rural communities in Japan in 2003. After overnight fasting, body mass index, blood pressure in the sitting position (SBP / DBP), baPWV in the supine position, plasma glucose level, total cholesterol level, triglyceride level, HDL cholesterol level and plasma DHEAS level were measured. The subjects were divided into two age groups, 70 years of age or older (70 or older group) and less than 70 years of age (under 70 group). The subjects in each age groups were further divided into two DHEAS level groups, a high DHEAS (≥2148 ng/ml in subjects < 70 years of age and ≥1053 ng/ml in subjects ≥ 70 years of age) group (H-DHEAS subgroup) and a normal DHEAS (< 2148 ng/ml in subjects < 70 years of age and < 1053 ng/ml in subjects ≥70 years of age) group (N-DHEAS subgroup). [Results] The level of baPWV showed significantly positive correlations with age (r = 0.737, p < 0.001), SBP and DBP and a negative correlation with DHEAS (r =-0.481, p < 0.001). In the under 70 group, baPWV was significantly lower in the H-DHEAS subgroup than in the N-DHEAS subgroup (p = 0.015), though age was lower in the H-DHEAS subgroup than in the N-DHEAS subgroup. In the 70 or older group, baPWV was significantly lower in the H-DHEAS subgroup than in the N-DHEAS subgroup (p = 0.014) and there was no statistically significant difference between age in the H-DHEAS subgroup and that in the N-DHEAS subgroup. [Conclusions] DHEAS level is strongly influenced by aging. In this study, it was shown that baPWV increased as the level of DHEAS decreased and that a decrease in DHEAS level is one of the factors related to the progression of arteriosclerosis.
AbstractList [Aim] To determine the relationship between dehydroepiandrosterone sulfate (DHEAS) levels and brachial-ankle pulse wave velocity (baPWV) in men.[Methods] The subjects were 114 men aged 59.1 ± 16.6 years, after exclusion of patients undergoing treatment for hypertension, diabetes and hyperlipidemia and patients with ABI of 0.9 or less, who participated in mass-screening tests in rural communities in Japan in 2003. After overnight fasting, body mass index, blood pressure in the sitting position (SBP / DBP), baPWV in the supine position, plasma glucose level, total cholesterol level, triglyceride level, HDL cholesterol level and plasma DHEAS level were measured. The subjects were divided into two age groups, 70 years of age or older (70 or older group) and less than 70 years of age (under 70 group). The subjects in each age groups were further divided into two DHEAS level groups, a high DHEAS (≥2148 ng/ml in subjects < 70 years of age and ≥1053 ng/ml in subjects ≥ 70 years of age) group (H-DHEAS subgroup) and a normal DHEAS (< 2148 ng/ml in subjects < 70 years of age and < 1053 ng/ml in subjects ≥70 years of age) group (N-DHEAS subgroup).[Results] The level of baPWV showed significantly positive correlations with age (r = 0.737, p < 0.001), SBP and DBP and a negative correlation with DHEAS (r =-0.481, p < 0.001). In the under 70 group, baPWV was significantly lower in the H-DHEAS subgroup than in the N-DHEAS subgroup (p = 0.015), though age was lower in the H-DHEAS subgroup than in the N-DHEAS subgroup. In the 70 or older group, baPWV was significantly lower in the H-DHEAS subgroup than in the N-DHEAS subgroup (p = 0.014) and there was no statistically significant difference between age in the H-DHEAS subgroup and that in the N-DHEAS subgroup.[Conclusions] DHEAS level is strongly influenced by aging. In this study, it was shown that baPWV increased as the level of DHEAS decreased and that a decrease in DHEAS level is one of the factors related to the progression of arteriosclerosis. [目的] Dehydroepiandrosterone sulfate (DHEAS) とbrachial-ankle pulse wave velocity (baPWV) との関係を検討した。[方法] 対象は2003年地域住民検診受診者のうち、高血圧、糖尿病、高脂血症治療者およびABI0.9以下を除外した男性114名 (平均年齢59.1±16.6歳) 。測定項目は早朝空腹時下におけるbody mass index (BMI) 、安静座位での血圧値 (SBP/DBP) 、安静臥位でのbaPWV値、空腹時血糖値、総コレステロール値、中性脂肪値、HDLコレステロール値、血清DHEAS値である。対象を70歳以上、未満に分け、DHEASを三分位しそれぞれ最高値の2148ng/ml以上 (70歳未満) 、1053ng/ml以上 (70歳以上) をH-DHEAS群、それ以外をN-DHEAS群とし、DHEASとbaPWVとの関係を検討した。[結果] baPWVは年齢 (r=0.737, p<0.001) 、SBP、DBPと有意な正の相関を、DHEASと有意な負の相関 (r=-0.481, p<0.001) を認めた。70歳以上、未満での検討では、70歳未満ではN-DHEAS群に比しH-DHEAS群の方がbaPWVは有意に (p=0.015) 低値を示したが、年齢も有意に低値であった。一方、70歳以上の群ではN-DHEAS群とH-DHEAS群との問に年齢に有意差を認めることなく、N-DHEAS群に比しH-DHEAS群の方がbaPWVは有意に低値となった (p=0.014) 。[結論] DHEASは年齢の影響を強く受けるものの、DHEASの低下とbaPWVの上昇は関係していることが示され、DHEASは動脈硬化進展と関連する可能性が示された。
[Aim] To determine the relationship between dehydroepiandrosterone sulfate (DHEAS) levels and brachial-ankle pulse wave velocity (baPWV) in men. [Methods] The subjects were 114 men aged 59.1 ± 16.6 years, after exclusion of patients undergoing treatment for hypertension, diabetes and hyperlipidemia and patients with ABI of 0.9 or less, who participated in mass-screening tests in rural communities in Japan in 2003. After overnight fasting, body mass index, blood pressure in the sitting position (SBP / DBP), baPWV in the supine position, plasma glucose level, total cholesterol level, triglyceride level, HDL cholesterol level and plasma DHEAS level were measured. The subjects were divided into two age groups, 70 years of age or older (70 or older group) and less than 70 years of age (under 70 group). The subjects in each age groups were further divided into two DHEAS level groups, a high DHEAS (≥2148 ng/ml in subjects < 70 years of age and ≥1053 ng/ml in subjects ≥ 70 years of age) group (H-DHEAS subgroup) and a normal DHEAS (< 2148 ng/ml in subjects < 70 years of age and < 1053 ng/ml in subjects ≥70 years of age) group (N-DHEAS subgroup). [Results] The level of baPWV showed significantly positive correlations with age (r = 0.737, p < 0.001), SBP and DBP and a negative correlation with DHEAS (r =-0.481, p < 0.001). In the under 70 group, baPWV was significantly lower in the H-DHEAS subgroup than in the N-DHEAS subgroup (p = 0.015), though age was lower in the H-DHEAS subgroup than in the N-DHEAS subgroup. In the 70 or older group, baPWV was significantly lower in the H-DHEAS subgroup than in the N-DHEAS subgroup (p = 0.014) and there was no statistically significant difference between age in the H-DHEAS subgroup and that in the N-DHEAS subgroup. [Conclusions] DHEAS level is strongly influenced by aging. In this study, it was shown that baPWV increased as the level of DHEAS decreased and that a decrease in DHEAS level is one of the factors related to the progression of arteriosclerosis.
Author Nakamura, Yosuke
Chiba, Yu
Fujiwara, Tadashi
Shimamoto, Kazuaki
Isobe, Takeshi
Saitoh, Shigeyuki
Takagi, Satoru
Takeuchi, Hiroshi
Katoh, Nobuo
Author_FL 千葉 雄
島本 和明
斎藤 重幸
竹内 宏
磯部 健
中村 陽介
高木 覚
藤原 禎
加藤 伸郎
Author_FL_xml – sequence: 1
  fullname: 磯部 健
– sequence: 2
  fullname: 斎藤 重幸
– sequence: 3
  fullname: 高木 覚
– sequence: 4
  fullname: 竹内 宏
– sequence: 5
  fullname: 千葉 雄
– sequence: 6
  fullname: 加藤 伸郎
– sequence: 7
  fullname: 藤原 禎
– sequence: 8
  fullname: 中村 陽介
– sequence: 9
  fullname: 島本 和明
Author_xml – sequence: 1
  fullname: Takagi, Satoru
  organization: Second Department of Intemal Medicine, Sapporo Medical University, School of Medicine
– sequence: 1
  fullname: Isobe, Takeshi
  organization: Second Department of Intemal Medicine, Sapporo Medical University, School of Medicine
– sequence: 1
  fullname: Katoh, Nobuo
  organization: Second Department of Intemal Medicine, Sapporo Medical University, School of Medicine
– sequence: 1
  fullname: Fujiwara, Tadashi
  organization: Second Department of Intemal Medicine, Sapporo Medical University, School of Medicine
– sequence: 1
  fullname: Takeuchi, Hiroshi
  organization: Second Department of Intemal Medicine, Sapporo Medical University, School of Medicine
– sequence: 1
  fullname: Shimamoto, Kazuaki
  organization: Second Department of Intemal Medicine, Sapporo Medical University, School of Medicine
– sequence: 1
  fullname: Nakamura, Yosuke
  organization: Second Department of Intemal Medicine, Sapporo Medical University, School of Medicine
– sequence: 1
  fullname: Chiba, Yu
  organization: Second Department of Intemal Medicine, Sapporo Medical University, School of Medicine
– sequence: 1
  fullname: Saitoh, Shigeyuki
  organization: Second Department of Intemal Medicine, Sapporo Medical University, School of Medicine
BackLink https://cir.nii.ac.jp/crid/1390282680156041856$$DView record in CiNii
BookMark eNo9kEtrwzAQhHVIoWmbH9CbDr06XT28to8lTR_g0kJfRyHLm0ZGVYLtBPzv65CSywzsfAzLXLBJ3ERi7FrAXAiVi9umcfVWAoi5PpxwwqZCaUxQYnbOZl3XAICSqpCZnrLyntZD3W5o620cveupHQv5-y6sbE-8pD2Fjo8Zf9uFjvi33RP_orBxvh-4j3wZamrDwF8oXrGzlR2h2b9fss-H5cfiKSlfH58Xd2XSCJ1jkqkUK1KWQNcKURNVUgBVoDPEmpytCnTp-LPKUkKqXDpC4CpbAOFKoLpkN8fe6L1x_qBCFSBziTmIFEGLPD1gyyPWdL39IbNt_a9tB2Pb3rtA5rSU0WDkUcbBTrlb29ZQVH-w02e0
ContentType Journal Article
Copyright The Japanese Association for Cerebro-cardiovascular Disease Control
Copyright_xml – notice: The Japanese Association for Cerebro-cardiovascular Disease Control
DBID RYH
DOI 10.11381/jjcdp2001.40.116
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate 男性高齢者のDehydroepiandrosterone sulfate(DHEAS)とPulse wave velocity(PWV)により評価した動脈硬化進展の関連―端野・壮瞥町研究
端野・壮瞥町研究
DocumentTitle_FL 男性高齢者のDehydroepiandrosterone sulfate(DHEAS)とPulse wave velocity(PWV)により評価した動脈硬化進展の関連―端野・壮瞥町研究
EndPage 122
ExternalDocumentID 130003662113
article_jjcdp2001_40_2_40_2_116_article_char_en
GroupedDBID ABJNI
ALMA_UNASSIGNED_HOLDINGS
JSP
KQ8
MOJWN
RJT
RYH
ID FETCH-LOGICAL-j1486-7356be3ae04d3664eeb210eb04766decab96c5346375e6ebc56640cba90e6f163
ISSN 1346-6267
IngestDate Thu Jun 26 21:05:20 EDT 2025
Wed Sep 03 06:29:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1486-7356be3ae04d3664eeb210eb04766decab96c5346375e6ebc56640cba90e6f163
OpenAccessLink https://www.jstage.jst.go.jp/article/jjcdp2001/40/2/40_2_116/_article/-char/en
PageCount 7
ParticipantIDs nii_cinii_1390282680156041856
jstage_primary_article_jjcdp2001_40_2_40_2_116_article_char_en
PublicationCentury 2000
PublicationDate 2005
PublicationDateYYYYMMDD 2005-01-01
PublicationDate_xml – year: 2005
  text: 2005
PublicationDecade 2000
PublicationTitle Japanese Journal of Cardiovascular Disease Prevention
PublicationTitleAlternate JJCDP
PublicationTitle_FL 日本循環器病予防学会誌
JJCDP
日循予防誌
PublicationYear 2005
Publisher The Japanese Association for Cerebro-cardiovascular Disease Control
社団法人 日本循環器管理研究協議会
Publisher_xml – name: The Japanese Association for Cerebro-cardiovascular Disease Control
– name: 社団法人 日本循環器管理研究協議会
References 23) 吉村正蔵.血管物性と動脈硬化.動脈硬化3, 1975;223-231.
34) Schriock ED, Buffington CK, Hubert GD, et al. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J Clin Endocrinol Metab 1988 ; 66 : 1329-1331.
37) 日本高血圧学会高血圧治療ガイドライン作成委員会.高血圧治療ガイドライン2000年版 (JSH 2000).東京 : 日本高血圧学会, 2000; 13-19.
24) 戸田源二, 矢野捷介.脈派速度.東京 : MEDICAL VIEW, 2002; 64-70.
25) Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, et al. Correlates of aortic stiffness in elderly individuals : a subgroup of the cardiovascular health study. Am J Hypertens 2002; 15 : 16-23.
36) Schwartz AG, Whitcomb JM, Nyce JW, et al. Dehydroepiandrosterone and structural analogs : a new class of cancer chemopreventive agents. Adv Cancer Res 1988 ; 51 : 391-424.
22) Blather J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33 : 1111-1117.
27) Nowaczynski W, Fragachan F, Silah J, et al. Further evidence of altered adrenocortical function in hypertension. Dehydroepiandrosterone excretion rate. Can J Biochem 1968 ; 46 : 1031-1038.
16) Coleman DL, Schwizer RW, Leiter EH. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetesobesity mutants and in aged normal mice. Diabetes 1984 ; 33 : 26-32.
32) Nestler JE, Clore JN, Strauss JF, III, et al. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 1987 ; 64 : 180-184.
15) Gordon GB, Bush DE, Weisman HF. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury. J Clin Invest 1988 ; 82 : 712-720.
18) 大西浩文, 斎藤重幸, 高木覚, 他.糖尿病における動脈硬化進展指標としてのPulse Wave Velocity (PWV) の有用性に関する検討-端野・壮瞥町研究より-.糖尿病, 2002;45 : 195-198.
2) 増田善昭.動脈波 (その6).エレクトロニクスの臨床, 1981; 10 : 131-144.
12) Nestler JE, Barlascini CO, Clore JN, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988 ; 66 : 57-61.
29) Coleman DL, Leiter EH, Schwizer RW. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982 ; 31 : 830-833.
17) Thulesius 0, Gjores JE. Use of doppler shift detection for determining peripheral arterial blood pressure. Angiology 1971 ; 22 : 594-603.
13) Barrett-Connor E, Khaw KT, Yen SSC. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986 ; 315 : 1519-1524.
7) Parker LN, Odell WD. Control of adrenal androgen secretion. Endocr Rev 1980 ; 1 : 392-410.
14) Schwartz AG, Whitcomb JM, Nyce JW, et al. Dehydroepiandrosterone and structural analogs : a new class of cancer chemopreventive agents. Adv Cancer Res 1988 ; 51 : 391-424.
30) Coleman DL, Schwizer RW, Leiter EH. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetesobesity mutants and in aged normal mice. Diabetes 1984 ; 33 : 26-32.
28) Ando S, Rubens R, Rottiers R. Androgen plasma levels in male diabetics. J Endocrinol Invest 1984; 7 : 21-24.
6) Baulieu EE. Studies of conjugated 17-ketosteroids in a case of adrenal tumor. J Clin Endcrinol Metab 1962 ; 22 : 501-510.
9) 名和田新, 土師正文, 柳瀬敏彦.副腎性性ステロイド.内分泌学の進歩, 1993; 10 : 227-235.
11) Liu CH, Laughlin GA, Fischer UG, et al. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women : evidence for a reduced 17, 20-desmolase enzymatic activity. J Clin Endocrinol Metab 1990 ; 71 : 900-906.
8) Orentreich N, Brind JL, Rizer RL, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endcrinol Metab 1984 ; 59 : 551-555.
10) Parker CR, Jr., Mixon RL, Brissie RM, et al. Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 1997 ; 82 : 3898-3901.
19) 平井昭.面積脈波の基礎的検討, および, 脈派速度の臨床的観察.千葉医会誌, 1967; 43 : 507-538.
31) Sonka J, Fassati M, Fassati P, et al. Serum lipids and dehydroepiandrosterone excretion in normal subjects. J Lipid Res 1968 ; 9 : 769-772.
35) Buffington CK, Givens JR, Kitabchi AE. Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. Diabetes 1991 ; 40 : 693-700.
5) Vande Wiele RL, MacDonald PC, Gurpide E, et al. Studies on the secretion and interconversion of the androgens. Recent Prog Horm Res 1963 ; 19 : 275-310.
3) 小澤利男, 増田善昭.脈派速度.東京 : MEDICAL VIEW, 2002 ; 26-34.
20) 林哲郎.動脈硬化症の研究生体大動脈脈派速度による大動脈硬化度の定量的測定と臨床応用に関する研究.慈医誌, 1970; 85 : 548-567.
4) Sun K, Daimon M, Watanabe S, et al. The relation of pulse wave velocities measured by oscillometric and tonometric methods and clinical application studies. Jpn J Appl Physiol 2002 ; 32 : 81-86.
26) Nestler JE, Barlascini CO, Clore JN, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988; 66 : 57-61.
33) Nestler JE, Clore JN, Blackard WG. Metabolism and actions of dehydroepiandrosterone in humans. J Steriod Biochem Molec Biol 1991 ; 40 : 599-605.
1) 長谷川元治.ヒト大動脈脈波速度に関する基礎的研究.慈医誌, 1970; 85 : 742-760.
21) Tomiyama H, Yamashina A, Arai T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement-a survey of 12517 subjects. Atherosclerosis 2003; 166 : 303-309.
References_xml – reference: 30) Coleman DL, Schwizer RW, Leiter EH. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetesobesity mutants and in aged normal mice. Diabetes 1984 ; 33 : 26-32.
– reference: 8) Orentreich N, Brind JL, Rizer RL, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endcrinol Metab 1984 ; 59 : 551-555.
– reference: 14) Schwartz AG, Whitcomb JM, Nyce JW, et al. Dehydroepiandrosterone and structural analogs : a new class of cancer chemopreventive agents. Adv Cancer Res 1988 ; 51 : 391-424.
– reference: 26) Nestler JE, Barlascini CO, Clore JN, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988; 66 : 57-61.
– reference: 33) Nestler JE, Clore JN, Blackard WG. Metabolism and actions of dehydroepiandrosterone in humans. J Steriod Biochem Molec Biol 1991 ; 40 : 599-605.
– reference: 28) Ando S, Rubens R, Rottiers R. Androgen plasma levels in male diabetics. J Endocrinol Invest 1984; 7 : 21-24.
– reference: 15) Gordon GB, Bush DE, Weisman HF. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury. J Clin Invest 1988 ; 82 : 712-720.
– reference: 5) Vande Wiele RL, MacDonald PC, Gurpide E, et al. Studies on the secretion and interconversion of the androgens. Recent Prog Horm Res 1963 ; 19 : 275-310.
– reference: 36) Schwartz AG, Whitcomb JM, Nyce JW, et al. Dehydroepiandrosterone and structural analogs : a new class of cancer chemopreventive agents. Adv Cancer Res 1988 ; 51 : 391-424.
– reference: 13) Barrett-Connor E, Khaw KT, Yen SSC. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986 ; 315 : 1519-1524.
– reference: 20) 林哲郎.動脈硬化症の研究生体大動脈脈派速度による大動脈硬化度の定量的測定と臨床応用に関する研究.慈医誌, 1970; 85 : 548-567.
– reference: 27) Nowaczynski W, Fragachan F, Silah J, et al. Further evidence of altered adrenocortical function in hypertension. Dehydroepiandrosterone excretion rate. Can J Biochem 1968 ; 46 : 1031-1038.
– reference: 34) Schriock ED, Buffington CK, Hubert GD, et al. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J Clin Endocrinol Metab 1988 ; 66 : 1329-1331.
– reference: 37) 日本高血圧学会高血圧治療ガイドライン作成委員会.高血圧治療ガイドライン2000年版 (JSH 2000).東京 : 日本高血圧学会, 2000; 13-19.
– reference: 2) 増田善昭.動脈波 (その6).エレクトロニクスの臨床, 1981; 10 : 131-144.
– reference: 4) Sun K, Daimon M, Watanabe S, et al. The relation of pulse wave velocities measured by oscillometric and tonometric methods and clinical application studies. Jpn J Appl Physiol 2002 ; 32 : 81-86.
– reference: 11) Liu CH, Laughlin GA, Fischer UG, et al. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women : evidence for a reduced 17, 20-desmolase enzymatic activity. J Clin Endocrinol Metab 1990 ; 71 : 900-906.
– reference: 1) 長谷川元治.ヒト大動脈脈波速度に関する基礎的研究.慈医誌, 1970; 85 : 742-760.
– reference: 35) Buffington CK, Givens JR, Kitabchi AE. Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. Diabetes 1991 ; 40 : 693-700.
– reference: 25) Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, et al. Correlates of aortic stiffness in elderly individuals : a subgroup of the cardiovascular health study. Am J Hypertens 2002; 15 : 16-23.
– reference: 10) Parker CR, Jr., Mixon RL, Brissie RM, et al. Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 1997 ; 82 : 3898-3901.
– reference: 12) Nestler JE, Barlascini CO, Clore JN, et al. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988 ; 66 : 57-61.
– reference: 19) 平井昭.面積脈波の基礎的検討, および, 脈派速度の臨床的観察.千葉医会誌, 1967; 43 : 507-538.
– reference: 29) Coleman DL, Leiter EH, Schwizer RW. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982 ; 31 : 830-833.
– reference: 9) 名和田新, 土師正文, 柳瀬敏彦.副腎性性ステロイド.内分泌学の進歩, 1993; 10 : 227-235.
– reference: 6) Baulieu EE. Studies of conjugated 17-ketosteroids in a case of adrenal tumor. J Clin Endcrinol Metab 1962 ; 22 : 501-510.
– reference: 22) Blather J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33 : 1111-1117.
– reference: 16) Coleman DL, Schwizer RW, Leiter EH. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetesobesity mutants and in aged normal mice. Diabetes 1984 ; 33 : 26-32.
– reference: 7) Parker LN, Odell WD. Control of adrenal androgen secretion. Endocr Rev 1980 ; 1 : 392-410.
– reference: 31) Sonka J, Fassati M, Fassati P, et al. Serum lipids and dehydroepiandrosterone excretion in normal subjects. J Lipid Res 1968 ; 9 : 769-772.
– reference: 3) 小澤利男, 増田善昭.脈派速度.東京 : MEDICAL VIEW, 2002 ; 26-34.
– reference: 18) 大西浩文, 斎藤重幸, 高木覚, 他.糖尿病における動脈硬化進展指標としてのPulse Wave Velocity (PWV) の有用性に関する検討-端野・壮瞥町研究より-.糖尿病, 2002;45 : 195-198.
– reference: 32) Nestler JE, Clore JN, Strauss JF, III, et al. The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 1987 ; 64 : 180-184.
– reference: 21) Tomiyama H, Yamashina A, Arai T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement-a survey of 12517 subjects. Atherosclerosis 2003; 166 : 303-309.
– reference: 24) 戸田源二, 矢野捷介.脈派速度.東京 : MEDICAL VIEW, 2002; 64-70.
– reference: 17) Thulesius 0, Gjores JE. Use of doppler shift detection for determining peripheral arterial blood pressure. Angiology 1971 ; 22 : 594-603.
– reference: 23) 吉村正蔵.血管物性と動脈硬化.動脈硬化3, 1975;223-231.
SSID ssj0003239274
ssib000872030
ssib005902230
ssib029852151
Score 1.4158739
Snippet [Aim] To determine the relationship between dehydroepiandrosterone sulfate (DHEAS) levels and brachial-ankle pulse wave velocity (baPWV) in men. [Methods] The...
[Aim] To determine the relationship between dehydroepiandrosterone sulfate (DHEAS) levels and brachial-ankle pulse wave velocity (baPWV) in men.[Methods] The...
SourceID nii
jstage
SourceType Publisher
StartPage 116
SubjectTerms Aging
DHEAS
PWV
Sex Hormones
加齢
性ホルモン
Title Dehydroepiandrosterone Sulfate Levels and Pulse Wave Velocity in Elderly Men
URI https://www.jstage.jst.go.jp/article/jjcdp2001/40/2/40_2_116/_article/-char/en
https://cir.nii.ac.jp/crid/1390282680156041856
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Journal of Cardiovascular Disease Prevention, 2005/04/30, Vol.40(2), pp.116-122
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  issn: 1346-6267
  databaseCode: KQ8
  dateStart: 20010101
  customDbUrl:
  isFulltext: true
  dateEnd: 20071231
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  omitProxy: true
  ssIdentifier: ssj0003239274
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe68cILAgFijCE_8BZlpInjNC-TUDdUoYFA7WBvkT8ua7qprbrmofw9_KHcxWnwRiU-XqzWqSLb9-vd7-y7M2Nv-koLMyiTMFM5peSkEGqVJ2Gqrc4HYGRsaL_j4yc5uhAfLtPLXu-HF7VUr_Wx-b4zr-R_pIp9KFfKkv0HyXYvxQ78jPLFFiWM7V_J-BSmG7tawBJlbCl9A1YLJI3j-qZEChmcU0CQq8H8uUYTGHyjq4a-Atov4t7VPDijO7pvNhTbeoelogWlmykDj64O7waunrqDnWBbAmrhgYziNybqGm6nVbeBo1BzTIPxtLqCTX3d9ePP1FUVjMn1r71OoDtaglGFk2pfst2ZSDsUNVlt25F6MGsiJ4ewQm9_EZrdwx66CH1PJSdChuh2Zb7OdiWeWmzGngLu96Vny_su5_l3M4E8hezEzNglBZUdC-q8V5Lb-UhJU7JHop-c7LEHMe360NH_F5_E0lG2p_Vy5EW_vsf5ICVe1e38JTFy0szdttxOrT1up2G9vT8opEYzdBSoAsTevKo89jN5zB61OODvHAafsN5MPWXnu_HHW_xxhz-Oz3iDP07441v88WrOW_xxxN8zdvH-bDIche3tHOEMXWgZZkkqNSQKImFxgQSAjvsR6EhkUlowSufSpDjDJEtBgjboOIjIoCaIQJboBjxn-3Mc1AvGB7JMTYlUFEortFVKy1ygLbIxCJtKe8BO3BIUS1eCpWj_ckW3WIWIitg1uGbdc0pdRE1xwI5w6QpTUYs-D200yEFTRYCKN8mXf3h-yB42JXubrbdXbH-9quEIyehav26w8BPezIrB
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dehydroepiandrosterone+Sulfate+Levels+and+Pulse+Wave+Velocity+in+Elderly+Men&rft.jtitle=Japanese+Journal+of+Cardiovascular+Disease+Prevention&rft.au=Isobe+Takeshi&rft.au=Saitoh+Shigeyuki&rft.au=Takagi+Satoru&rft.au=Takeuchi+Hiroshi&rft.date=2005&rft.pub=The+Japanese+Association+for+Cerebro-cardiovascular+Disease+Control&rft.issn=1346-6267&rft.volume=40&rft.issue=2&rft.spage=116&rft.epage=122&rft_id=info:doi/10.11381%2Fjjcdp2001.40.116&rft.externalDocID=130003662113
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-6267&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-6267&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-6267&client=summon